In relation to MGMT methylation, serum FAP levels show no discernible differences between grade 4 glioma and grade 2 glioma, and grade 3 glioma (Fig. 1 IIIh; P2 = 0.1643, P3 = 0.2254). The gene discussed is MGMT; the disease is central nervous system cancer.